The DOI matches its Crossref record; 167 of the 167 references it cites were found in a registry or an index.
Cell Penetrating Peptides as Molecular Carriers for Anti-Cancer Agents
Open accessAbstract
Cell membranes with their selective permeability play important functions in the tight control of molecular exchanges between the cytosol and the extracellular environment as the intracellular membranes do within the internal compartments. For this reason the plasma membranes often represent a challenging obstacle to the intracellular delivery of many anti-cancer molecules. The active transport of drugs through such barrier often requires specific carriers able to cross the lipid bilayer. Cell penetrating peptides (CPPs) are generally 5–30 amino acids long which, for their ability to cross cell membranes, are widely used to deliver proteins, plasmid DNA, RNA, oligonucleotides, liposomes and anti-cancer drugs inside the cells. In this review, we describe the several types of CPPs, the chemical modifications to improve their cellular uptake, the different mechanisms to cross cell membranes and their biological properties upon conjugation with specific molecules. Special emphasis has been given to those with promising application in cancer therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regulated portals of entry into the cell
Conner, S. D., & Schmid, S. L. (2003) · Nature · doi:10.1038/nature01451 · Cited by 3,805
Cellular uptake of the tat protein from human immunodeficiency virus
Frankel, A. D., & Pabo, C. O. (1988) · Cell · doi:10.1016/0092-8674(88)90263-2 · Cited by 2,783
A short amino acid sequence able to specify nuclear location
Kalderon, D., Roberts, B. L., Richardson, W. D., & Smith, A. E. (1984) · Cell · doi:10.1016/0092-8674(84)90457-4 · Cited by 2,507
Progress and problems with the use of viral vectors for gene therapy
Thomas, C. E., Ehrhardt, A., & Kay, M. A. (2003) · Nature Reviews Genetics · doi:10.1038/nrg1066 · Cited by 2,501
Vivès, E., Brodin, P., & Lebleu, B. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.25.16010 · Cited by 2,373
The third helix of the Antennapedia homeodomain translocates through biological membranes.
Derossi, D., Joliot, A. H., Chassaing, G., & Prochiantz, A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)34080-2 · Cited by 2,034
Shai, Y. (1999) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(99)00200-x · Cited by 1,869
Futaki, S., Suzuki, T., Ohashi, W., Yagami, T., Tanaka, S., Ueda, K., & Sugiura, Y. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007540200 · Cited by 1,662
Wadia, J. S., Stan, R. V., & Dowdy, S. F. (2004) · Nature Medicine · doi:10.1038/nm996 · Cited by 1,647
Wender, P. A., Mitchell, D. J., Pattabiraman, K., Pelkey, E. T., Steinman, L., & Rothbard, J. B. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.24.13003 · Cited by 1,615
Endosomal escape pathways for delivery of biologicals
Varkouhi, A. K., Scholte, M., Storm, G., & Haisma, H. J. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.11.004 · Cited by 1,561
Green, M., & Loewenstein, P. M. (1988) · Cell · doi:10.1016/0092-8674(88)90262-0 · Cited by 1,553
Robbins, J., Dilwortht, S. M., Laskey, R. A., & Dingwall, C. (1991) · Cell · doi:10.1016/0092-8674(91)90245-t · Cited by 1,489
Richard, J. P., Melikov, K., Vives, E., Ramos, C., Verbeure, B., Gait, M. J., Chernomordik, L. V., & Lebleu, B. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209548200 · Cited by 1,446
Cell-Penetrating Peptides: From Basic Research to Clinics
Guidotti, G., Brambilla, L., & Rossi, D. (2017) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2017.01.003 · Cited by 1,147
Polyarginine enters cells more efficiently than other polycationic homopolymers
Mitchell, D. J., Steinman, L., Kim, D. T., Fathman, C. G., & Rothbard, J. B. (2000) · The Journal of Peptide Research · doi:10.1034/j.1399-3011.2000.00723.x · Cited by 1,084
Twenty years of cell‐penetrating peptides: from molecular mechanisms to therapeutics
Heitz, F., Morris, M. C., & Divita, G. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00057.x · Cited by 867
Cell‐penetrating peptides: 20 years later, where do we stand?
Bechara, C., & Sagan, S. (2013) · FEBS Letters · doi:10.1016/j.febslet.2013.04.031 · Cited by 857
Tumor imaging by means of proteolytic activation of cell-penetrating peptides
Jiang, T., Olson, E. S., Nguyen, Q. T., Roy, M., Jennings, P. A., & Tsien, R. Y. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408191101 · Cited by 822
Cell-penetrating peptides: classes, origin, and current landscape
Milletti, F. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2012.03.002 · Cited by 813
A Comprehensive Model for the Cellular Uptake of Cationic Cell‐penetrating Peptides
Duchardt, F., Fotin‐Mleczek, M., Schwarz, H., Fischer, R., & Brock, R. (2007) · Traffic · doi:10.1111/j.1600-0854.2007.00572.x · Cited by 771
Cellular Uptake of Arginine-Rich Peptides: Roles for Macropinocytosis and Actin Rearrangement
Nakase, I., Niwa, M., Takeuchi, T., Sonomura, K., Kawabata, N., Koike, Y., Takehashi, M., Tanaka, S., Ueda, K., Simpson, J. C., et al. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2004.08.010 · Cited by 752
Pelkmans, L., & Helenius, A. (2002) · Traffic · doi:10.1034/j.1600-0854.2002.30501.x · Cited by 747
Pouny, Y., Rapaport, D., Mor, A., Nicolas, P., & Shai, Y. (1992) · Biochemistry · doi:10.1021/bi00164a017 · Cited by 687
Cationic TAT peptide transduction domain enters cells by macropinocytosis
Kaplan, I. M., Wadia, J. S., & Dowdy, S. F. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.10.018 · Cited by 668
Antennapedia homeobox peptide regulates neural morphogenesis.
Joliot, A., Pernelle, C., Deagostini-Bazin, H., & Prochiantz, A. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.5.1864 · Cited by 654
Rothbard, J. B., Jessop, T. C., Lewis, R. S., Murray, B. A., & Wender, P. A. (2004) · Journal of the American Chemical Society · doi:10.1021/ja0482536 · Cited by 624
Richard, J. P., Melikov, K., Brooks, H., Prevot, P., Lebleu, B., & Chernomordik, L. V. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m401604200 · Cited by 604
Three-dimensional visualization of coated vesicle formation in fibroblasts.
Heuser, J. (1980) · The Journal of cell biology · doi:10.1083/jcb.84.3.560 · Cited by 579
Hydrophobic interactions of peptides with membrane interfaces
White, S. H., & Wimley, W. C. (1998) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/s0304-4157(98)00021-5 · Cited by 556
“SMART” Drug Delivery Systems: Double-Targeted pH-Responsive Pharmaceutical Nanocarriers
Sawant, R. M., Hurley, J. P., Salmaso, S., Kale, A., Tolcheva, E., Levchenko, T. S., & Torchilin, V. P. (2006) · Bioconjugate Chemistry · doi:10.1021/bc060080h · Cited by 540
Simeoni, F. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg385 · Cited by 480
Cell Membrane Lipid Rafts Mediate Caveolar Endocytosis of HIV-1 Tat Fusion Proteins
Fittipaldi, A., Ferrari, A., Zoppé, M., Arcangeli, C., Pellegrini, V., Beltram, F., & Giacca, M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303045200 · Cited by 475
Nguyen, Q. T., Olson, E. S., Aguilera, T. A., Jiang, T., Scadeng, M., Ellies, L. G., & Tsien, R. Y. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910261107 · Cited by 474
Mitochondria-Penetrating Peptides
Horton, K. L., Stewart, K. M., Fonseca, S. B., Guo, Q., & Kelley, S. O. (2008) · Chemistry & Biology · doi:10.1016/j.chembiol.2008.03.015 · Cited by 465
El-Sayed, A., Futaki, S., & Harashima, H. (2009) · The AAPS Journal · doi:10.1208/s12248-008-9071-2 · Cited by 465
Tumor penetrating peptides for improved drug delivery
Ruoslahti, E. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.03.008 · Cited by 459
Possible Existence of Common Internalization Mechanisms among Arginine-rich Peptides
Suzuki, T., Futaki, S., Niwa, M., Tanaka, S., Ueda, K., & Sugiura, Y. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110017200 · Cited by 430
Structural and functional characterization of human immunodeficiency virus tat protein
Ruben, S., Perkins, A., Purcell, R., Joung, K., Sia, R., Burghoff, R., Haseltine, W. A., & Rosen, C. A. (1989) · Journal of Virology · doi:10.1128/jvi.63.1.1-8.1989 · Cited by 429
Assembly and function of RNA silencing complexes
Sontheimer, E. J. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1568 · Cited by 423
Erazo-Oliveras, A., Muthukrishnan, N., Baker, R., Wang, T.-Y., & Pellois, J.-P. (2012) · Pharmaceuticals · doi:10.3390/ph5111177 · Cited by 384
Clathrin-dependent endocytosis
MOUSAVI, S. A., MALERØD, L., BERG, T., & KJEKEN, R. (2004) · Biochemical Journal · doi:10.1042/bj20031000 · Cited by 375
Cell‐penetrating peptides: from molecular mechanisms to therapeutics
Morris, M. C., Deshayes, S., Heitz, F., & Divita, G. (2008) · Biology of the Cell · doi:10.1042/bc20070116 · Cited by 361
Eguchi, A., Meade, B. R., Chang, Y.-C., Fredrickson, C. T., Willert, K., Puri, N., & Dowdy, S. F. (2009) · Nature Biotechnology · doi:10.1038/nbt.1541 · Cited by 340
Mechanism Matters: A Taxonomy of Cell Penetrating Peptides
Kauffman, W. B., Fuselier, T., He, J., & Wimley, W. C. (2015) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2015.10.004 · Cited by 333
Mitochondria-targeted peptide antioxidants: Novel neuroprotective agents
Szeto, H. H. (2006) · The AAPS Journal · doi:10.1208/aapsj080362 · Cited by 332
CPPsite 2.0: a repository of experimentally validated cell-penetrating peptides
Agrawal, P., Bhalla, S., Usmani, S. S., Singh, S., Chaudhary, K., Raghava, G. P. S., & Gautam, A. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1266 · Cited by 332
Secondary structure of cell-penetrating peptides controls membrane interaction and insertion
Eiríksdóttir, E., Konate, K., Langel, Ü., Divita, G., & Deshayes, S. (2010) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2010.03.005 · Cited by 323
Martin, M. E., & Rice, K. G. (2007) · The AAPS Journal · doi:10.1208/aapsj0901003 · Cited by 319
EL Andaloussi, S., Lehto, T., Mäger, I., Rosenthal-Aizman, K., Oprea, I. I., Simonson, O. E., Sork, H., Ezzat, K., Copolovici, D. M., Kurrikoff, K., et al. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkq1299 · Cited by 301
Nanopreparations for organelle-specific delivery in cancer
Biswas, S., & Torchilin, V. P. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.11.004 · Cited by 292
Farkhani, S. M., Valizadeh, A., Karami, H., Mohammadi, S., Sohrabi, N., & Badrzadeh, F. (2014) · Peptides · doi:10.1016/j.peptides.2014.04.015 · Cited by 273
Reissmann, S. (2014) · Journal of Peptide Science · doi:10.1002/psc.2672 · Cited by 266
Almeida, P. F., & Pokorny, A. (2009) · Biochemistry · doi:10.1021/bi900914g · Cited by 265
Olson, E. S., Aguilera, T. A., Jiang, T., Ellies, L. G., Nguyen, Q. T., Wong, E. H., Gross, L. A., & Tsien, R. Y. (2009) · Integrative Biology · doi:10.1039/b904890a · Cited by 263
Protein Prenylation: Enzymes, Therapeutics, and Biotechnology Applications
Palsuledesai, C. C., & Distefano, M. D. (2015) · ACS Chemical Biology · doi:10.1021/cb500791f · Cited by 259
Potential efficacy of cell-penetrating peptides for nucleic acid and drug delivery in cancer
Bolhassani, A. (2011) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2011.07.006 · Cited by 257
Ziegler, A. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.10.005 · Cited by 255
Pan, L., Liu, J., He, Q., Wang, L., & Shi, J. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2012.12.040 · Cited by 252
Effects of cargo molecules on the cellular uptake of arginine-rich cell-penetrating peptides
Maiolo, J. R., Ferrer, M., & Ottinger, E. A. (2005) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2005.04.010 · Cited by 251
Dubikovskaya, E. A., Thorne, S. H., Pillow, T. H., Contag, C. H., & Wender, P. A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805374105 · Cited by 249
Protein transduction domain delivery of therapeutic macromolecules
van den Berg, A., & Dowdy, S. F. (2011) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2011.03.008 · Cited by 247
Review self‐assembly of amphipathic β‐sheet peptides: Insights and applications
Bowerman, C. J., & Nilsson, B. L. (2012) · Peptide Science · doi:10.1002/bip.22058 · Cited by 244
Actin remodeling to facilitate membrane fusion
Eitzen, G. (2003) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(03)00087-9 · Cited by 242
Ezzat, K., EL Andaloussi, S., Zaghloul, E. M., Lehto, T., Lindberg, S., Moreno, P. M. D., Viola, J. R., Magdy, T., Abdo, R., Guterstam, P., et al. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr072 · Cited by 236
Cell-penetrating peptides: strategies for anticancer treatment
Raucher, D., & Ryu, J. S. (2015) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2015.06.005 · Cited by 234
TAT Peptide Internalization: Seeking the Mechanism of Entry
Vives, E., Richard, J., Rispal, C., & Lebleu, B. (2003) · Current Protein & Peptide Science · doi:10.2174/1389203033487306 · Cited by 225
McCarthy, H. O., McCaffrey, J., McCrudden, C. M., Zholobenko, A., Ali, A. A., McBride, J. W., Massey, A. S., Pentlavalli, S., Chen, K.-H., Cole, G., et al. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.06.048 · Cited by 216
Proline-rich, amphipathic cell-penetrating peptides
Pujals, S., & Giralt, E. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.09.012 · Cited by 209
Lindgren, M., Rosenthal-Aizman, K., Saar, K., Eiríksdóttir, E., Jiang, Y., Sassian, M., Östlund, P., Hällbrink, M., & Langel, Ü. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.10.048 · Cited by 207
TAT-modified nanosilver for combating multidrug-resistant cancer
Liu, J., Zhao, Y., Guo, Q., Wang, Z., Wang, H., Yang, Y., & Huang, Y. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.05.035 · Cited by 205
Spontaneous Membrane-Translocating Peptides by Orthogonal High-Throughput Screening
Marks, J. R., Placone, J., Hristova, K., & Wimley, W. C. (2011) · Journal of the American Chemical Society · doi:10.1021/ja2017416 · Cited by 203
Peptides for cell-selective drug delivery
Svensen, N., Walton, J. G. A., & Bradley, M. (2012) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2012.02.002 · Cited by 195
Targeting cyclin B1 through peptide-based delivery of siRNA prevents tumour growth
Crombez, L., Morris, M. C., Dufort, S., Aldrian-Herrada, G., Nguyen, Q., Mc Master, G., Coll, J.-L., Heitz, F., & Divita, G. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp451 · Cited by 193
Cell‐Penetrating Homochiral Cyclic Peptides as Nuclear‐Targeting Molecular Transporters
Mandal, D., Nasrolahi Shirazi, A., & Parang, K. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201102572 · Cited by 191
Warso, M. A., Richards, J. M., Mehta, D., Christov, K., Schaeffer, C., Rae Bressler, L., Yamada, T., Majumdar, D., Kennedy, S. A., Beattie, C. W., et al. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.74 · Cited by 190
Pharmacogenetics of irinotecan metabolism and transport: An update
Smith, N. F., Figg, W. D., & Sparreboom, A. (2006) · Toxicology in Vitro · doi:10.1016/j.tiv.2005.06.045 · Cited by 190
Komin, A., Russell, L. M., Hristova, K. A., & Searson, P. C. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.06.002 · Cited by 189
Legumain protease-activated TAT-liposome cargo for targeting tumours and their microenvironment
Liu, Z., Xiong, M., Gong, J., Zhang, Y., Bai, N., Luo, Y., Li, L., Wei, Y., Liu, Y., Tan, X., et al. (2014) · Nature Communications · doi:10.1038/ncomms5280 · Cited by 185
Functionalized Nanoscale Micelles Improve Drug Delivery for Cancer Therapy in Vitro and in Vivo
Wei, T., Liu, J., Ma, H., Cheng, Q., Huang, Y., Zhao, J., Huo, S., Xue, X., Liang, Z., & Liang, X.-J. (2013) · Nano Letters · doi:10.1021/nl400586t · Cited by 183
Nakase, I., Konishi, Y., Ueda, M., Saji, H., & Futaki, S. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.01.016 · Cited by 168
Mechanism of Uptake of C105Y, a Novel Cell-penetrating Peptide
Rhee, M., & Davis, P. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m509813200 · Cited by 164
Dinca, A., Chien, W.-M., & Chin, M. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17020263 · Cited by 164
Tumour lineage-homing cell-penetrating peptides as anticancer molecular delivery systems
Kondo, E., Saito, K., Tashiro, Y., Kamide, K., Uno, S., Furuya, T., Mashita, M., Nakajima, K., Tsumuraya, T., Kobayashi, N., et al. (2012) · Nature Communications · doi:10.1038/ncomms1952 · Cited by 162
Heparan Sulfate: A Ubiquitous Glycosaminoglycan with Multiple Roles in Immunity
Simon Davis, D. A., & Parish, C. R. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00470 · Cited by 161
Molecular Parameters of siRNA–Cell Penetrating Peptide Nanocomplexes for Efficient Cellular Delivery
van Asbeck, A. H., Beyerle, A., McNeill, H., Bovee-Geurts, P. H. M., Lindberg, S., Verdurmen, W. P. R., Hällbrink, M., Langel, Ü., Heidenreich, O., & Brock, R. (2013) · ACS Nano · doi:10.1021/nn305754c · Cited by 160
Savariar, E. N., Felsen, C. N., Nashi, N., Jiang, T., Ellies, L. G., Steinbach, P., Tsien, R. Y., & Nguyen, Q. T. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-2969 · Cited by 159
O’Callaghan, K., Kuliopulos, A., & Covic, L. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.r112.355461 · Cited by 159
Verdurmen, W. P. R., Bovée‐Geurts, P. H. M., Wadhwani, P., Ulrich, A. S., Hällbrink, M., Kuppevelt, T. H. V., & Brock, R. E. (2011) · Chemistry & Biology · doi:10.1016/j.chembiol.2011.06.006 · Cited by 150
Salomone, F., Cardarelli, F., Luca, M. D., Boccardi, C., Nifosì, R., Bardi, G., Bari, L. D., Serresi, M., & Beltram, F. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.09.019 · Cited by 147
In vivo biodistribution and efficacy of peptide mediated delivery
Järver, P., Mäger, I., & Langel, Ü. (2010) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2010.07.006 · Cited by 145
Rydberg, H. A., Dzebo, M. M., Åmand, H. L., Esbjörner, E. K., & Nordén, B. (2012) · Biochemistry · doi:10.1021/bi300454k · Cited by 143
Intracellular transduction using cell-penetrating peptides
Sawant, R. R., & Torchilin, V. P. (2009) · Molecular BioSystems · doi:10.1039/b916297f · Cited by 142
Park, J., Ryu, J., Kim, K.-A., Lee, H. J., Bahn, J. H., Han, K., Choi, E. Y., Lee, K. S., Kwon, H. Y., & Choi, S. Y. (2002) · Journal of General Virology · doi:10.1099/0022-1317-83-5-1173 · Cited by 140
de Coupade, C., Fittipaldi, A., Chagnas, V., Michel, M., Carlier, S., Tasciotti, E., Darmon, A., Ravel, D., Kearsey, J., Giacca, M., et al. (2005) · Biochemical Journal · doi:10.1042/bj20050401 · Cited by 139
PSA-responsive and PSMA-mediated multifunctional liposomes for targeted therapy of prostate cancer
Xiang, B., Dong, D., Shi, N., Gao, W., Yang, Z., Cui, Y., De-ying, C., & Qi, X. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.05.055 · Cited by 139
Matrix metalloproteinase 2-responsive micelle for siRNA delivery
Wang, H., Yang, X., Sun, C., Mao, C., Zhu, Y., & Wang, J. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.05.050 · Cited by 130
Tan, M., Lan, K., Yao, J., Lu, C., Sun, M., Neal, C. L., Lü, J., & Yu, D. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2747 · Cited by 129
Novel cell‐penetrating peptide targeting mitochondria
Cerrato, C. P., Pirisinu, M., Vlachos, E. N., & Langel, Ü. (2015) · The FASEB Journal · doi:10.1096/fj.14-269225 · Cited by 127
Dietrich, L., Rathmer, B., Ewan, K., Bange, T., Heinrichs, S., Dale, T. C., Schade, D., & Grossmann, T. N. (2017) · Cell Chemical Biology · doi:10.1016/j.chembiol.2017.06.013 · Cited by 126 · cited 1×
“Different strategies have been used to produce chemically modified hydrophobic, such as peptide stapling for structurally-stabilized α-helical peptide with the capacity to resist proteolysis [32], prenylation to increase the affinity to cell membranes [33], and the pepducin technology to potentially identify new drug…”
MethodAroui, S., Brahim, S., WAARD, M. M. D., & Kénani, A. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.11.073 · Cited by 122
A peptide fragment of azurin induces a p53-mediated cell cycle arrest in human breast cancer cells
Yamada, T., Mehta, R. R., Lekmine, F., Christov, K. T., King, M. L., Majumdar, D., Shilkaitis, A. L., Green, A., Bratescu, L., Beattie, C. W., et al. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0444 · Cited by 118
Mehta, R. R., Yamada, T., Taylor, B. N., Christov, K. T., King, M. L., Majumdar, D., Lekmine, F., Tiruppathì, C., Shilkaitis, A. L., Bratescu, L., et al. (2011) · Angiogenesis · doi:10.1007/s10456-011-9220-6 · Cited by 117
Endosomal escape and the knockdown efficiency of liposomal-siRNA by the fusogenic peptide shGALA
Sakurai, Y., Hatakeyama, H., Sato, Y., Akita, H., Takayama, K., Kobayashi, S., Futaki, S., & Harashima, H. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.04.047 · Cited by 114
Cellular Import Mediated by Nuclear Localization Signal Peptide Sequences
Ragin, A. D., Morgan, R. A., & Chmielewski, J. A. (2002) · Chemistry & Biology · doi:10.1016/s1074-5521(02)00189-8 · Cited by 112
Gerbal‐Chaloin, S., Gondeau, C., Aldrian, G., Heitz, F., Gauthier‐Rouvière, C., & Divita, G. (2007) · Biology of the Cell · doi:10.1042/bc20060123 · Cited by 110
Controlled release of free doxorubicin from peptide–drug conjugates by drug loading
Chen, Z., Zhang, P., Cheetham, A. G., Moon, J. H., Moxley, J. W., Lin, Y., & Cui, H. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.05.051 · Cited by 109
Duong, H. H. P., & Yung, L. L. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.06.017 · Cited by 108
PepFect14 Peptide Vector for Efficient Gene Delivery in Cell Cultures
Veiman, K.-L., Mäger, I., Ezzat, K., Margus, H., Lehto, T., Langel, K., Kurrikoff, K., Arukuusk, P., Suhorutšenko, J., Padari, K., et al. (2012) · Molecular Pharmaceutics · doi:10.1021/mp3003557 · Cited by 105
Wang, H., Zhao, Y., Wang, H., Gong, J., He, H., Shin, M. C., Yang, V. C.-M., & Huang, Y. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.06.051 · Cited by 105
A cell-penetrating peptide from a novel pVII–pIX phage-displayed random peptide library
Gao, C., Mao, S., Ditzel, H. J., Farnaes, L., Wirsching, P., Lerner, R. A., & Janda, K. D. (2002) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(02)00340-1 · Cited by 103
TAT conjugated cationic noble metal nanoparticles for gene delivery to epidermal stem cells
Peng, L., Niu, J., Zhang, C., Yu, W., Wu, J., Shan, Y.-H., Wang, X.-R., Shen, Y., Mao, Z., Liang, W., et al. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.03.062 · Cited by 103
Chen, J., Li, S., & Shen, Q. (2012) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2012.07.002 · Cited by 98
CPP-Assisted Intracellular Drug Delivery, What Is Next?
Ye, J., Liu, E., Yu, Z., Pei, X., Chen, S., Zhang, P., Shin, M. C., Gong, J., He, H., & Yang, V. C.-M. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17111892 · Cited by 97
New generation of efficient peptide-based vectors, NickFects, for the delivery of nucleic acids
Arukuusk, P., Pärnaste, L., Oskolkov, N., Copolovici, D. M., Margus, H., Padari, K., Möll, K., Maslovskaja, J., Tegova, R., Kivi, G., et al. (2013) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2013.01.011 · Cited by 93
Nakamura, T., Yamazaki, D., Yamauchi, J., & Harashima, H. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.07.004 · Cited by 92
Therapeutic Potential of cell-penetrating Peptides
Vasconcelos, D., Pärn, K., & Langel, Ü. (2013) · Therapeutic Delivery · doi:10.4155/tde.13.22 · Cited by 92
Aroui, S., Brahim, S., WAARD, M. M. D., Bréard, J., & Kénani, A. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.04.044 · Cited by 89
Fu, H., Shi, K., Hu, G., Yang, Y., Kuang, Q., Lu, L., Zhang, L., Chen, W., Dong, M., Chen, Y., et al. (2014) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.24291 · Cited by 87
Induction of in vivo synthetic lethal RNAi responses to treat glioblastoma
Michiue, H., Eguchi, A., Scadeng, M., & Dowdy, S. F. (2009) · Cancer Biology & Therapy · doi:10.4161/cbt.8.23.10271 · Cited by 81
Classes of Cell-Penetrating Peptides
Pooga, M., & Langel, Ü. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2806-4_1 · Cited by 81
Jeong, J., Kim, K., Lim, D., Jeong, K., Hong, Y., Nguyen, V. H., Kim, T., Ryu, S., Lim, J.-A., Kim, J. I., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0080050 · Cited by 79
Glycosaminoglycans in the cellular uptake of drug delivery vectors – Bystanders or active players?
Favretto, M. E., Wallbrecher, R., Schmidt, S., van de Putte, R., & Brock, R. E. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.02.011 · Cited by 78
Kuai, R., Yuan, W., Li, W., Qin, Y., Tang, J., Yuan, M., Fu, L., Ran, R., Zhang, Z., & He, Q. (2011) · Molecular Pharmaceutics · doi:10.1021/mp200100f · Cited by 76
Govindarajan, S., Jeyarajan, S., Garimidi, P., Rangaraj, N., Kumar, J. M., Rao, N. M., & Gopal, V. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.12.003 · Cited by 75
Hitz, T., Iten, R., Gardiner, J., Namoto, K., Walde, P., & Seebàch, D. (2006) · Biochemistry · doi:10.1021/bi060285d · Cited by 74
Tanaka, K., Kanazawa, T., Shibata, Y., Suda, Y., Fukuda, T., Takashima, Y., & Okada, H. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.06.028 · Cited by 72
Cyclic Peptide-Capped Gold Nanoparticles as Drug Delivery Systems
Shirazi, A. N., Mandal, D., Tiwari, R. K., Guo, L., Lü, W., & Parang, K. (2012) · Molecular Pharmaceutics · doi:10.1021/mp300448k · Cited by 72
Jia, L., Gorman, G. S., Coward, L. U., Noker, P. E., McCormick, D. L., Horn, T. L., Harder, J. B., Muzzio, M., Prabhakar, B. S., Ganesh, B. B., et al. (2010) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-010-1518-3 · Cited by 71
DTS-108, A Novel Peptidic Prodrug of SN38: In vivo Efficacy and Toxicokinetic Studies
Meyer-Losic, F., Nicolazzi, C., Quinonero, J., Ribes, F., Michel, M., Dubois, V., de Coupade, C., Boukaissi, M., Chéné, A.-S., Tranchant, I., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4580 · Cited by 70
Tréhin, R., Krauss, U., Beck‐Sickinger, A. G., Merkle, H. P., & Nielsen, H. M. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000033013.45204.c3 · Cited by 65
Hsieh, T., Hsu, C., Tsai, C., Chiu, C., Liang, S., Wang, T., Kuo, P., Long, C., & Tsai, E. (2016) · Scientific Reports · doi:10.1038/srep19156 · Cited by 65
Perillo, E., Hervé-Aubert, K., Allard-Vannier, É., Falanga, A., Galdiero, S., & Chourpa, I. (2017) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2017.03.106 · Cited by 65
Shuttle‐mediated nanoparticle transport across an in vitro brain endothelium under flow conditions
Falanga, A. P., Pitingolo, G., Celentano, M., Cosentino, A., Melone, P., Vecchione, R., Guarnieri, D., & Netti, P. A. (2016) · Biotechnology and Bioengineering · doi:10.1002/bit.26221 · Cited by 63
Preparation and characterization of nonaarginine-modified chitosan nanoparticles for siRNA delivery
Park, S., Jeong, E. J., Lee, J., Rhim, T., Lee, S. K., & Lee, K. Y. (2012) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2012.08.116 · Cited by 60
“Alternative” endocytic mechanisms exploited by pathogens: New avenues for therapeutic delivery?☆
Medina‐Kauwe, L. K. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.06.009 · Cited by 58
Application of a Proapoptotic Peptide to Intratumorally Spreading Cancer Therapy
Chen, R., Braun, G. B., Luo, X., Sugahara, K. N., Teesalu, T., & Ruoslahti, E. I. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-1979 · Cited by 58
Foerg, C., Ziegler, U., Fernández‐Carneado, J., Giralt, E., & Merkle, H. P. (2007) · Pharmaceutical Research · doi:10.1007/s11095-006-9212-1 · Cited by 57
Zhang, J., Shin, M. C., David, A. E., Zhou, J., Lee, K., He, H., & Yang, V. C.-M. (2013) · Molecular Pharmaceutics · doi:10.1021/mp400360q · Cited by 57
Baoum, A. A., Ovcharenko, D., & Berkland, C. J. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.08.012 · Cited by 57
Lindberg, S., Muñoz‐Alarcón, A., Helmfors, H., Mosqueira, D., Gyllborg, D., Tudoran, O. M., & Langel, Ü. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.11.037 · Cited by 55
Shin, M. C., Zhang, J., Min, K. A., Lee, K., Moon, C., Balthasar, J. P., & Yang, V. C.-M. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.08.030 · Cited by 54
Comparative study on the interaction of cell-penetrating polycationic polymers with lipid membranes
Takechi, Y., Tanaka, H., Kitayama, H., Yoshii, H., Tanaka, M., & Saito, H. (2011) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2011.11.002 · Cited by 53
Yamada, T., Das Gupta, T. K., & Beattie, C. W. (2013) · Molecular Pharmaceutics · doi:10.1021/mp400221r · Cited by 51
Borrelli, A., Schiattarella, A., Bonelli, P., Tuccillo, F. M., Buonaguro, F. M., & Mancini, A. (2014) · BioMed Research International · doi:10.1155/2014/476789 · Cited by 50
Self-citationA Novel Intracellular Peptide Derived from G1/S Cyclin D2 Induces Cell Death
de Araujo, C. B., Russo, L. C., de Castro, L. M., Forti, F. L., do Monte, E. R., Rioli, V., Gozzo, F. C., Colquhoun, A., & Ferro, E. S. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.537118 · Cited by 49
Liu, S., Yang, H., Wan, L., Cheng, J., & Lu, X. (2013) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2012.1328 · Cited by 49
Cell-penetrating peptides as tools to enhance non-injectable delivery of biopharmaceuticals
Kristensen, M., & Nielsen, H. M. (2016) · Tissue Barriers · doi:10.1080/21688370.2016.1178369 · Cited by 47
LAH4 enhances CD8+ T cell immunity of protein/peptide-based vaccines
Zhang, T., Kang, T. H., Ma, B., Xu, Y., Hung, C., & Wu, T. ‐. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.11.056 · Cited by 46
A novel cell-penetrating peptide TAT-A1 delivers siRNA into tumor cells selectively
Fang, B., Lu, J., Zhang, M., & Ren, F. (2012) · Biochimie · doi:10.1016/j.biochi.2012.09.020 · Cited by 44
Ryu, J. S., & Raucher, D. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.03.021 · Cited by 40
Chen, J., Xu, X., Yang, S., Yang, J., Zhuo, R., & Zhang, X. (2012) · Macromolecular Bioscience · doi:10.1002/mabi.201200283 · Cited by 38
Rajpal, Mann, A., Khanduri, R., Naik, R. J., & Ganguli, M. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.09.081 · Cited by 37
Akita, H., Masuda, T., Nishio, T., Niikura, K., Ijiro, K., & Harashima, H. (2011) · Molecular Pharmaceutics · doi:10.1021/mp200189s · Cited by 36
Perillo, E., Allard-Vannier, É., Falanga, A., Stiuso, P., Vitiello, M. T., Galdiero, M., Galdiero, S., & Chourpa, I. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.04.039 · Cited by 35
Recommendations for Benchmarking Preclinical Studies of Nanomedicines
Dawidczyk, C. M., Russell, L. M., & Searson, P. C. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-1558 · Cited by 34
Deng, X., Qiu, Q., Yang, B., Wang, X., Huang, W., & Qian, H. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.10.072 · Cited by 31
Magnetic tumor targeting of β-glucosidase immobilized iron oxide nanoparticles
Zhou, J., Zhang, J., David, A. E., & Yang, V. C.-M. (2013) · Nanotechnology · doi:10.1088/0957-4484/24/37/375102 · Cited by 29
Coriat, R., Faivre, S. J., Mir, O., Dreyer, C., Ropert, S., Bouattour, M., Desjardins, R., Goldwasser, F., & Raymond, É. (2016) · International Journal of Nanomedicine · doi:10.2147/ijn.s110274 · Cited by 28
Lewis, H. D., Husain, A., DONNELLY, R. J., Barlos, D., Riaz, S., Ginjupalli, K., Shodeinde, A., & Barton, B. E. (2010) · BMC Biotechnology · doi:10.1186/1472-6750-10-79 · Cited by 25
Mével, M., Haudebourg, T., Colombani, T., et al. (2015) · The Journal of Gene Medicine · doi:10.1002/jgm.2869 · Cited by 24
LXXLL Peptide Converts Transportan 10 to a Potent Inducer of Apoptosis in Breast Cancer Cells
Tints, K., Prink, M., Neuman, T., & Palm, K. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15045680 · Cited by 24
Weyland, M., Griveau, A., Bejaud, J., Benoît, J., Coursaget, P., & Garcion, E. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.06.013 · Cited by 21
Controlled delivery of BID protein fused with TAT peptide sensitizes cancer cells to apoptosis
Orzechowska-Licari, E. J., Kozłowska, E., Czubaty, A., Kozlowski, P., Staroń, K., & Trzcińska‐Danielewicz, J. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-771 · Cited by 21
ChemInform Abstract: Self‐Assembly of Amphipathic β‐Sheet Peptides: Insights and Applications
Bowerman, C. J., & Nilsson, B. L. (2012) · ChemInform · doi:10.1002/chin.201236225 · Cited by 21
謝宗樺, 許珈旖, 蔡承芳, 邱建智, 梁世欣, 王姿乃, 郭柏麟, 龍震宇, 蔡英美, Hsieh, et al. (2016) · Cited by 21
Photodynamic therapy by conjugation of cell-penetrating peptide with fluorochrome
Park, C., Kim, Y. H., Hwangbo, S., & Cho, H. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s148332 · Cited by 13
Cited by
Xie, J., Bi, Y., Zhang, H., Dong, S., Teng, L., Lee, R. J., & Yang, Z. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00697 · Cited by 466
Antimicrobial Peptides as Anticancer Agents: Functional Properties and Biological Activities
Tornesello, A. L., Borrelli, A., Buonaguro, L., Buonaguro, F. M., & Tornesello, M. L. (2020) · Molecules · doi:10.3390/molecules25122850 · Cited by 383
Self-citationTesauro, D., Accardo, A., Diaferia, C., Milano, V., Guillon, J., Ronga, L., & Rossi, F. (2019) · Molecules · doi:10.3390/molecules24020351 · Cited by 225
Gessner, I., & Neundorf, I. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072536 · Cited by 212
Advances in mesoporous silica nanoparticles for targeted stimuli-responsive drug delivery: An update
Castillo, R. R., Lozano, D., González, B., Manzano, M., Izquierdo-Barba, I., & Vallet-Regí, M. (2019) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2019.1598375 · Cited by 197
Metadata
- Authors
- Borrelli, A., Tornesello, A., Tornesello, M., & Buonaguro, F.
- Venue
- Molecules
- Publisher
- MDPI AG
- Published
- 2018-01-31
- Volume
- 23
- Issue
- 2
- Pages
- 295
- ISSN
- 1420-3049 (ISSN-L)
- OpenAlex
- W2789330875
- Cited by
- 295
- References
- 167
- FWCI
- 11.77
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.